T3+ and T4 Rectal Cancer Patients Seem to Benefit From the Addition of Oxaliplatin to the Neoadjuvant Chemoradiation Regimen

[1] Heald RJ(1986)Recurrence and survival after total mesorectal excision for rectal cancer Lancet. 1 1479-1482

[2] Ryall RD(1986)Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision Lancet. 2 996-999

[3] Quirke P(2008)Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy Eur J Cancer. 44 1710-1716

[4] Durdey P(2010)Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989–2006 Eur J Cancer. 46 1421-1429

[5] Dixon MF(2010)Quality assurance in rectal cancer treatment in the Netherlands: a catch up compared to colon cancer treatment Eur J Surg Oncol. 36 340-344

[6] Williams NS(2001)Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med. 345 638-646

[7] den Dulk M(2009)Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial Lancet. 373 811-820

[8] Krijnen P(2003)Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial Int J Radiat Oncol Biol Phys. 55 1311-1320

[9] Marijnen CA(2002)Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit Am J Surg Pathol. 26 350-357

[10] Rutten HJ(2007)Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer J Clin Oncol. 25 1647-1650

[1] Heald RJ(1986)Recurrence and survival after total mesorectal excision for rectal cancer Lancet. 1 1479-1482

[2] Ryall RD(1986)Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision Lancet. 2 996-999

[3] Quirke P(2008)Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy Eur J Cancer. 44 1710-1716

[4] Durdey P(2010)Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989–2006 Eur J Cancer. 46 1421-1429

[5] Dixon MF(2010)Quality assurance in rectal cancer treatment in the Netherlands: a catch up compared to colon cancer treatment Eur J Surg Oncol. 36 340-344

[6] Williams NS(2001)Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med. 345 638-646

[7] den Dulk M(2009)Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial Lancet. 373 811-820

[8] Krijnen P(2003)Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial Int J Radiat Oncol Biol Phys. 55 1311-1320

[9] Marijnen CA(2002)Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit Am J Surg Pathol. 26 350-357

[10] Rutten HJ(2007)Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer J Clin Oncol. 25 1647-1650